Cargando…

P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)

Detalles Bibliográficos
Autores principales: Shah, Bijal, Xue, Mei, Yang, Keri, Liu, Sizhu (Tom), Tang, Boxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431129/
http://dx.doi.org/10.1097/01.HS9.0000971336.22348.b6
_version_ 1785091127286693888
author Shah, Bijal
Xue, Mei
Yang, Keri
Liu, Sizhu (Tom)
Tang, Boxiong
author_facet Shah, Bijal
Xue, Mei
Yang, Keri
Liu, Sizhu (Tom)
Tang, Boxiong
author_sort Shah, Bijal
collection PubMed
description
format Online
Article
Text
id pubmed-10431129
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311292023-08-17 P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US) Shah, Bijal Xue, Mei Yang, Keri Liu, Sizhu (Tom) Tang, Boxiong Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431129/ http://dx.doi.org/10.1097/01.HS9.0000971336.22348.b6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Shah, Bijal
Xue, Mei
Yang, Keri
Liu, Sizhu (Tom)
Tang, Boxiong
P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
title P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
title_full P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
title_fullStr P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
title_full_unstemmed P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
title_short P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)
title_sort p1110: real-world treatment patterns of bruton tyrosine kinase inhibitors (btki) in patients with mantle cell lymphoma (mcl) in community oncology practices in the united states (us)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431129/
http://dx.doi.org/10.1097/01.HS9.0000971336.22348.b6
work_keys_str_mv AT shahbijal p1110realworldtreatmentpatternsofbrutontyrosinekinaseinhibitorsbtkiinpatientswithmantlecelllymphomamclincommunityoncologypracticesintheunitedstatesus
AT xuemei p1110realworldtreatmentpatternsofbrutontyrosinekinaseinhibitorsbtkiinpatientswithmantlecelllymphomamclincommunityoncologypracticesintheunitedstatesus
AT yangkeri p1110realworldtreatmentpatternsofbrutontyrosinekinaseinhibitorsbtkiinpatientswithmantlecelllymphomamclincommunityoncologypracticesintheunitedstatesus
AT liusizhutom p1110realworldtreatmentpatternsofbrutontyrosinekinaseinhibitorsbtkiinpatientswithmantlecelllymphomamclincommunityoncologypracticesintheunitedstatesus
AT tangboxiong p1110realworldtreatmentpatternsofbrutontyrosinekinaseinhibitorsbtkiinpatientswithmantlecelllymphomamclincommunityoncologypracticesintheunitedstatesus